Cargando…

Type I interferon response gene expression in established rheumatoid arthritis is not associated with clinical parameters

BACKGROUND: A peripheral blood interferon (IFN) signature (i.e., elevated type I interferon response gene [IRG] expression) has been described in a subset of patients with rheumatoid arthritis (RA). In the present study, we systematically assessed the association between this IRG expression and clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Jong, Tamarah D., Blits, Marjolein, de Ridder, Sander, Vosslamber, Saskia, Wolbink, Gertjan, Nurmohamed, Mike T., Verweij, Cornelis L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5154062/ https://www.ncbi.nlm.nih.gov/pubmed/27955694 http://dx.doi.org/10.1186/s13075-016-1191-y

Ejemplares similares

Effect of prednisone on type I interferon signature in rheumatoid arthritis: consequences for response prediction to rituximab
por: de Jong, Tamarah D, et al.
Publicado: (2015)

Moving towards personalized medicine in rheumatoid arthritis
por: de Jong, Tamarah D, et al.
Publicado: (2014)

The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
por: Raterman, Hennie G, et al.
Publicado: (2012)

The type I interferon signature in leukocyte subsets from peripheral blood of patients with early arthritis: a major contribution by granulocytes
por: de Jong, Tamarah D., et al.
Publicado: (2016)

Combining DNA-microarray data in systemic lupus erythematosus
por: Verweij, Cornelis L, et al.
Publicado: (2011)

Dynamics of the Type I Interferon Response During Immunosuppressive Therapy in Rheumatoid Arthritis
por: de Jong, Tamarah D., et al.
Publicado: (2019)

Changes in peripheral blood lymphocyte subsets during arthritis development in arthralgia patients
por: Lübbers, Joyce, et al.
Publicado: (2016)

Physiological evidence for diversification of IFNα- and IFNβ-mediated response programs in different autoimmune diseases
por: de Jong, Tamarah D., et al.
Publicado: (2016)

Cardiovascular risk management in rheumatoid arthritis: are we still waiting for the first step?
por: Peters, Mike JL, et al.
Publicado: (2013)

Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production
por: Castañeda-Delgado, Julio E., et al.
Publicado: (2017)

Adherence to etanercept therapy in rheumatoid arthritis patients during 3 years of follow-up
por: Vogelzang, E. H., et al.
Publicado: (2018)

Atherogenic lipid profiles and its management in patients with rheumatoid arthritis
por: Nurmohamed, Michael T
Publicado: (2007)

The increased cardiovascular risk in rheumatoid arthritis: when does it start?
por: Nurmohamed, Michael T
Publicado: (2010)

Interferon-β for treatment of rheumatoid arthritis?
por: van Holten, Judith, et al.
Publicado: (2002)

Cardiovascular risk in inflammatory arthritis: rheumatoid arthritis and gout
por: Hansildaar, Romy, et al.
Publicado: (2021)

Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
por: Dijkshoorn, Bas, et al.
Publicado: (2022)

Patients with rheumatic diseases adhere to COVID-19 isolation measures more strictly than the general population
por: Hooijberg, Femke, et al.
Publicado: (2020)

Pharmacogenomics of Interferon-ß Therapy in Multiple Sclerosis: Baseline IFN Signature Determines Pharmacological Differences between Patients
por: van Baarsen, Lisa G. M., et al.
Publicado: (2008)

Recombinant interferon alpha 2b in rheumatoid arthritis: good antigen for rheumatoid arthritis antibodies
por: Ali Khan, Wahid
Publicado: (2018)

Unresolved Questions in Rheumatology: Motion for Debate: The Data Support Evidence-Based Management Recommendations for Cardiovascular Disease in Rheumatoid Arthritis
por: Solomon, Daniel H, et al.
Publicado: (2013)

The Effect of Anti-TNF Therapy on Cardiac Function in Rheumatoid Arthritis: An Observational Study
por: Baniaamam, Milad, et al.
Publicado: (2020)

Cardiovascular risk in persons at risk of developing rheumatoid arthritis
por: van Boheemen, Laurette, et al.
Publicado: (2020)

Quality of life in Ecuadorian patients with established rheumatoid arthritis
por: Intriago, Maria, et al.
Publicado: (2019)

Comorbidities in Black South Africans with established rheumatoid arthritis
por: Lala, Vikash, et al.
Publicado: (2022)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

Lymphotoxin-LIGHT Pathway Regulates the Interferon Signature in Rheumatoid Arthritis
por: Bienkowska, Jadwiga, et al.
Publicado: (2014)

Correspondence on “Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: results from the COVID-19 global rheumatology alliance physician registry”
por: van Vollenhoven, Ronald F, et al.
Publicado: (2023)

Autoantibodies predict progression to rheumatoid arthritis in undifferentiated arthritis: a prospective cohort study
por: van Gaalen, FA, et al.
Publicado: (2003)

Comparison of the Belgian Rheumatoid Arthritis Disability Assessment and Health Assessment Questionnaires as Tools to Predict the Need for Support Measures in Patients with Rheumatoid Arthritis
por: Janssens, Xavier, et al.
Publicado: (2016)

Prevalence and severity of periodontitis in patients with established rheumatoid arthritis and osteoarthritis
por: Disale, Pooja R., et al.
Publicado: (2020)

The establishment of a rheumatoid arthritis primate model in Macaca fascicularis
por: Na, Hyun Sik, et al.
Publicado: (2020)

Expansion of Rare and Harmful Lineages is Associated with Established Rheumatoid Arthritis
por: Mena-Vázquez, Natalia, et al.
Publicado: (2020)

Using adalimumab serum concentration to choose a subsequent biological DMARD in rheumatoid arthritis patients failing adalimumab treatment (ADDORA-switch): study protocol for a fully blinded randomised superiority test-treatment trial
por: Wientjes, Maike H. M., et al.
Publicado: (2021)

Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated
por: Raadsen, Reinder, et al.
Publicado: (2023)

Efficacy of tofacitinib monotherapy in methotrexate-naive patients with early or established rheumatoid arthritis
por: Fleischmann, Roy M, et al.
Publicado: (2016)

Disease activity trajectories for early and established rheumatoid arthritis: Real-world data from a rheumatoid arthritis cohort
por: Movahedi, Mohammad, et al.
Publicado: (2022)

Tapering towards DMARD-free remission in established rheumatoid arthritis: 2-year results of the TARA trial
por: van Mulligen, Elise, et al.
Publicado: (2020)

Quality of life in patients with established rheumatoid arthritis: A phenomenographic study
por: Malm, Karina, et al.
Publicado: (2017)

Rheumatoid Arthritis
por: de Forest, Gideon K.
Publicado: (1957)

Treadmill Running in Established Phase Arthritis Inhibits Joint Destruction in Rat Rheumatoid Arthritis Models
por: Fujii, Yuta, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_kjsgn5u6javkm7irrj29tp7h9g